Sizing the non-small-cell lung cancer (NSCLC) market with trusted epidemiology data

Exploring in-depth patient population insights in the fast-growing NSCLC market.

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, and represents one of the largest oncology therapy markets. In this infographic, Clarivate experts provide a snapshot of NSCLC epidemiology data, including:

  • Projected market size by 2032
  • Granular patient population by stage at diagnosis
  • Top comorbidities based on U.S. claims-based data
  • Insights into drug-treated vs non-drug treated populations